WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 5'7301 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 12'3741 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 9'468  9'511  9'553  9'597  9'647  10'272  9'735  9'057 
Births 91  93  94  96  97  122  147  170 
Surviving infants 90  92  93  95  96  121  144  164 
Pop. less than 5 years 463  472  481  491  503  613  759  814 
Pop. less than 15 years 1'519  1'543  1'567  1'595  1'627  2'075  2'367  2'223 
Female 15-49 years 2'292  2'309  2'326  2'344  2'361  2'614  2'367  2'312 

Number of reported case

(Click for retrospective incidence data for Serbia)
Diphtheria
Japanese encephalitis
Measles 37  370  20  38  4'978  37'441 
Mumps 63  64  584  63  40  1'215 
Pertussis 281  39  51  25  24  1'440  6'710 
Polio*
Rubella 11  14  14  14  2'188 
Rubella (CRS)
Tetanus (neonatal) 17 
Tetanus (total)** 24  57  99 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Serbia)
Vaccine year result method % card seen                                                
BCG 2013  98  MICS   87  98  97  98  99  99  99* 
DTP1 2013  93  MICS   87  98 
DTP3 2013  89  MICS   87  93  95  91  94  91  95 
HepB_BD          99 
HepB3          92  91  97  94  81 
Hib3 2013  83  MICS   87  94  92  90  93  91 
JapEnc         
MCV          86  92  87  93  95  89 
MCV2          91  82  90  90  91 
PCV1         
PCV3         
Pol3 2013  88  MICS   87  93  97  93  94  91  98 
Rota1         
Rota_last         
Rubella1          86  93 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Serbia)
BCG 97  98  99  99  85 
DTP1 98  91  98  91  97 
DTP3 95  91  94  91  95 
HepB3 91  97  94  89 
HepB_BD 99  99  99  99 
Hib3 92  90  93  91 
MCV 92  87  93  95  89 
MCV2 82  90  90  91  78 
PCV3
Pol3 97  93  94  91  98 
Rota_last

Number of districts in the country 25  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7 years; Yes
DTwP 8, 14, 20 weeks; 18 months; Yes
HIB 8, 14, 20 weeks; Yes
HepB_Adult special risk group
HepB_Pediatric birth; 4 weeks; 5 months; Yes
IPV adults over 65 years and chronic diseases patients
Influenza >=65 years; Yes chronic diseases patients
MMR 12 months; 7 years; Yes
MenAC some chronic diseases patients, travelers
OPV 8, 14, 20 weeks; 18 months; 7, 14 years; Yes
Pneumo_conj some chronic diseases patients
Pneumo_ps some chronic diseases patients
Td 14 years; Yes
Typhoid travelers
YF travelers

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No          Yes   
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number           25   

System performance

Total Nº districts in country number 25  25  25  25  25  25  25 
Nº districts with DTP3 coverage >=80% number 25  25  25  25  25  25 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number   16  13  22  16  22  21 
% of districts with MCV1 coverage >=95% From 0 to 100% 64  52  88  64  88  84 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND   No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR   Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%             100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No             

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.